Literature DB >> 11045725

Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans.

R T Dorr1, K Dvorakova, C Brooks, R Lines, N Levine, K Schram, P Miketova, V Hruby, D S Alberts.   

Abstract

Seven normal volunteers (six males and one female) with tanning skin types III or IV (Fitzpatrick scale) were given 10 daily subcutaneous injections of a superpotent synthetic analog of alpha-melanocyte stimulating hormone (alpha-MSH) over two weeks. This agent, [Nle4-D-Phe7]alpha-MSH, also called Melanotan-I (MT-I), was administered at a dose of 0.16 mg/kg/day (Monday-Friday), over a two week period. Tanning was measured serially using computerized light reflectance. This regimen induced tanning at 3 of 8 anatomic sites including the face, neck and forearm by comparison of baseline to (1) the end of the daily dosing period, (day 14), and (2) one week later, (day 21). Shave biopsies of the forearm taken at baseline and day 21 were analyzed by high performance liquid chromatography for eumelanin content which was measured as the permanganate oxidation product, pyrrole-2,3,5-tricarboxylic acid or PTCA. Pheomelanin content was measured as the hydroiodic acid digestion product, aminohydroxyphenylalanine (AHP). Eumelanin was also measured in the forehead skin samples of three subjects. The HPLC results show that mean (+/- SD) baseline eumelanin (PTCA) levels in forehead skin (n = 3) averaged 1.38 (+/- 0.87) ng/mg of wet skin tissue weight. Higher mean baseline levels of PTCA were detected in forearm skin (2.06 +/- 0.28 ng/mg wet weight, n = 7). One week after MT-I treatments ended, there was a mean (SD) 49% (+/- 17.6%) increase in forehead skin PTCA levels compared to baseline (P = 0.019, n = 3, by paired sample T-test). The mean (SD) increase in forearm skin PTCA levels was 98% (+/- 25.4%) over the same period (P = 0.003). In contrast, forearm pheomelanin expression following MT-I treatment did not significantly change from baseline. Overall, the MT-I regimen increased the eumelanin: pheomelanin ratio in forearm skin from 51:1 at baseline to 86:1 following MT-I (P = 0.054 by paired sample T-test). These results show that the tanning induced by MT-I in the face and forearm is associated with a significant increase in the eumelanin content of the human skin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045725     DOI: 10.1562/0031-8655(2000)072<0526:ieeati>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

Review 1.  Hypopigmentary skin disorders: current treatment options and future directions.

Authors:  Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  [Skin aging].

Authors:  E Kohl; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

Review 3.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

Review 4.  Prevention of non-melanoma skin cancer.

Authors:  S P Stratton
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

5.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

Review 6.  Organic chemistry and biology: chemical biology through the eyes of collaboration.

Authors:  Victor J Hruby
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

7.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 8.  Advances in the management of erythropoietic protoporphyria - role of afamelanotide.

Authors:  Ashley M Lane; Jerome T McKay; Herbert L Bonkovsky
Journal:  Appl Clin Genet       Date:  2016-12-12

9.  Promising agents for chemoprevention of skin cancer.

Authors:  S P Stratton; M S Stratton; D S Alberts
Journal:  Curr Oncol       Date:  2006-10       Impact factor: 3.677

Review 10.  The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids.

Authors:  Christine M Clemson; John Yost; Andrew W Taylor
Journal:  Ocul Immunol Inflamm       Date:  2016-01-25       Impact factor: 3.070

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.